Shibaura Institute creates potent vitamin K analogues
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Shibaura Institute of Technology synthesized 12 hybrid vitamin K homologues, linking some to retinoic acid, to boost neuronal activity.
- Yoshihisa Hirota reported that the new vitamin K analogues are about three times more effective at converting neural progenitor cells into neurons than natural vitamin K.
- Yoshitomo Suhara co‑led the research, emphasizing the compounds' promise for brain repair in neurodegenerative diseases.
- ACS Chemical Neuroscience published the study on July 3 2025, highlighting the analogues as potential regenerative agents for Alzheimer’s, Parkinson’s, and Huntington’s disease.
Why it matters: Patients with neurodegenerative diseases gain a regenerative therapy candidate that is three times more effective at neuron formation, reducing long‑term care demand and expanding Japan's biotech export market.
